Alerts will be sent to your verified email
Verify Email
ACCENTMIC
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
Accent Microcell Limited is engaged in the manufacturing business of Pharmaceutical Excipients Range of Product. The company has carved a niche in the production of high-quality cellulose-based excipients, that meet international quality standards.
Accent Microcell major competitors are Themis Medicare, Anuh Pharma, Bharat Parenterals, Wanbury, Fredun Pharma, Fermenta Biotech, Shree Ganesh Remed..
Market Cap of Accent Microcell is ₹808 Crs.
While the median market cap of its peers are ₹829 Crs.
Accent Microcell seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY26 | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | Mar | ||||||||||||||||||
| Investor Presentation | Mar | ||||||||||||||||||
| Conference Call | Mar | ||||||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
